In GBM samples, CD3+ lymphocytes represented an average of 72.7% of the CD45+ population and consisted mainly of CD4+ and CD8+ T lymphocytes which accounted for 40.1% and 32.3% of viable CD45+ cells, respectively. This evidence concerns the gene CD8A and glioblastoma.